Company

Metsera, Inc.

Metsera develops treatments for weight loss, weight maintenance, and disease prevention.

About

Founded in 2022 and based in New York, Metsera is a biopharmaceutical company developing treatment strategies for weight loss, weight maintenance, and disease prevention. In September 2025, Pfizer Inc. agreed to acquire the company for USD 65.60 per share, or USD 7 billion in cash, with potential additional payments of up to $20.65 per share tied to milestones.

2Funding rounds

15Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in